rpn-2 Antibody

Basic Research Questions

What are the primary biological functions of RPN2 in human cells?

RPN2 (Ribophorin-II) serves as a critical subunit of the oligosaccharyltransferase (OST) complex, catalyzing N-glycosylation by transferring glycan precursors to asparagine residues in nascent polypeptides . This process is essential for protein folding, quality control, and endoplasmic reticulum (ER) trafficking.

How should researchers validate RPN2 antibody specificity in Western blot?

• Use cell lysates with known RPN2 expression (e.g., RT4 bladder cancer cells as positive control, U-251 MG glioma cells for comparison) .

• Confirm a predicted band size of 69 kDa and compare with knockout cell lines if available .

• Cross-validate via siRNA-mediated RPN2 knockdown followed by immunoblotting .

What experimental applications are validated for anti-RPN2 antibodies?

The ab244399 antibody is validated for:

Advanced Research Challenges

How does RPN2 influence proteasome activity in disease models?

The E738K mutation in the rpn2 gene reduces 26S proteasome inhibition under oxidative stress, decreasing polyubiquitinated protein accumulation (e.g., in Plasmodium under artemisinin treatment) . Methodological considerations:

• Use proteasome activity assays (e.g., chymotrypsin-like activity) with/without oxidative stressors.

• Monitor ubiquitin-conjugate levels via immunoblotting with anti-polyubiquitin antibodies .

What signaling pathways are regulated by RPN2 in cancer?

In gliomas, RPN2 activates the Wnt/β-catenin pathway via GSK-3β phosphorylation, upregulating cyclin D1 and c-Myc . Experimental design tips:

• Combine RPN2 siRNA with luciferase-based TOPFlash reporters for Wnt activity.

• Co-stain for β-catenin nuclear localization in IHC .

How to address RPN2 antibody cross-reactivity in co-expressed markers?

• Optimize fluorophore combinations using tools like Fluorofinder to minimize spectral overlap .

• For flow cytometry, pair low-expressed RPN2 with bright fluorophores (e.g., PE-Cy7) and use FcR blocking agents to reduce nonspecific binding .

Data Analysis & Contradictions

How to resolve conflicting RPN2 expression data across glioma studies?

Discrepancies may arise from:

• Tumor heterogeneity: Use single-cell RNA sequencing to subtype-specific RPN2 expression.

• Antibody validation: Compare multiple clones (e.g., ab244399 vs. Sigma-Aldrich HPA058344) across cell lines .

Why do proteasome inhibition assays show variable results with RPN2 mutants?

• Phosphorylation states (e.g., Thr-273) alter proteasome stability .

• Use phosphatase inhibitors during lysate preparation and validate via Phos-tag SDS-PAGE .

Technical Optimization

How to improve RPN2 detection in high-autofluorescence samples?

• Switch to near-infrared fluorophores (e.g., AF790) for IHC.

• Pre-treat tissues with TrueStain Monocyte Blocker to reduce dye-myelin interactions .

What controls are essential for RPN2 co-localization studies?

• Include ER markers (e.g., Calnexin) for OST complex localization.

• Use CRISPR-Cas9 RPN2 KO cells as negative controls in IF experiments .

Emerging Research Directions

Can RPN2 serve as a biomarker for drug resistance?

In malaria, the E738K rpn2 variant confers reduced artemisinin sensitivity by stabilizing proteasome function . For cancer:

• Correlate RPN2 expression with chemotherapy resistance (e.g., paclitaxel IC50 values) using patient-derived xenografts .

What omics approaches integrate best with RPN2 studies?

• Phosphoproteomics to map RPN2 interaction partners (e.g., rpt3/rpt6 ATPase subunits) .

• Glycoproteomics to quantify N-glycosylation efficiency in RPN2-deficient models .